Dr. Leslie on the Utility of BTK Inhibitors in B-Cell Malignancies OncLive 1:00 4 years ago 45 Далее Скачать
Dr. Leslie on the Role of BTK Inhibitors in Relapsed/Refractory MCL OncLive 1:47 4 years ago 48 Далее Скачать
Dr. Ma on First- and Second-Generation BTK Inhibitors in B-Cell Malignancies OncLive 1:45 4 years ago 311 Далее Скачать
Identifying Differences Between BTK Inhibitors for B-Cell Malignancies Targeted Oncology 1:00 4 years ago 156 Далее Скачать
Lori Leslie, MD, considers how physicians should be thinking about the use of BTK inhibitors in CLL OBRoncology 1:24 5 years ago 15 Далее Скачать
BTK inhibitors and their place in the treatment landscape of B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 84 Далее Скачать
What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update Medscape 18:20 6 months ago 4 Далее Скачать
Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tom... Medscape 1:32:21 6 months ago 8 Далее Скачать
Comparing BTK Inhibitors in Patients With B-Cell Malignancies Targeted Oncology 1:01 4 years ago 255 Далее Скачать
Lori Leslie, MD, considers the use of zanubrutinib in relapsed/refractory mantle cell lymphoma OBRoncology 0:47 5 years ago 57 Далее Скачать
Dr. Burke on Current Indications for BTK Inhibitors in B-Cell Malignancies OncLive 1:55 4 years ago 91 Далее Скачать
Exploring Questions Remaining for BTK Inhibitors and B-Cell Malignancies Targeted Oncology 1:27 4 years ago 92 Далее Скачать
LOXO-35: a next gen BTK inhibitor for B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 1:54 5 years ago 571 Далее Скачать
Dr. Fenske on the Utility of Next-Generation BTK Inhibitors in MCL OncLive 1:05 4 years ago 106 Далее Скачать
